Cannabinoid-Receptor

Cat.No.	Product Name	Information	Area
T3530	Otenabant	Otenabant has been investigated for the treatment of Obesity.	Obesity
T4654	SLV319	SLV319 has been used in trials studying the treatment of Obesity and Obesity and Type...	Obesity
T4453	JD-5037	JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.	Endocrine metabolic disease;Diabetes mellitus; Hyperlipidaem
T9114	β-Caryophyllene	β-Caryophyllene is a CB2 receptor agonist.
T3584	JWH-133	JWH 133 is a potent CB2 selective agonist.	Others
T3699	Bay 59-3074	Bay 59-3074 is a CB1/CB2?receptor partial agonist (Ki: 48.3/45.5 nM). In rat model...
T6755	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 8...	Others
T1796	Otenabant hydrochloride	Otenabant hydrochloride (CP-945598) is a competitive, high affinity, selective antago...	Other
T6417	BML-190	BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selecti...	Nervous system
T6527	GW842166X	GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 recept...	Nervous system
T2635	Org 27569	Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 rece...	Endocrine system
T1915	AM251	AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-...	Other
T1519L	Rimonabant	Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic...	Metabolism system
T1519	Rimonabant hydrochloride	Rimonabant hydrochloride is a cannabinoid receptor antagonist, binding selectively to...	Metabolism system

Home 1 Last